• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals

  • Print
  • Share
  • E-mail
Generic Name: Chimeric (human-murine) G250 IgG monoclonal antibody
Date Designated: 07/24/2000
Orphan Designation: Treatment of renal cell carcinoma.
Orphan Designation Status: Designated/Withdrawn
FDA Orphan Approval Status: Not FDA Approved for Orphan Indication
Wilex Biotechnology GmbH
Grillparzerstrasse 10B
81675 Munich

The sponsor address listed is the last reported by the sponsor to OOPD.

*Exclusivity Protected Indications are shown for approvals from Jan. 1, 2013, to the present.